Trial no.:
|
PACTR201503001062685 |
Date of Approval:
|
08/03/2015 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Articaine versus Bupivacaine / Lidocaine mixture in episcleral peribulbar anesthesia for cataract surgery. A prospective randomized controlled study. |
Official scientific title |
80 patients of both sexes undergoing elective cataract surgery with peribulbar episcleral anesthesia. Patients will be randomly allocated into two groups, 40 patients each. Group A: 40 patients will receive peribulbar episcleral anesthesia using 2% articaine as a local anesthetic agent. Group B: 40 patients will receive peribulbar episcleral anesthesia using a mixture of 0.5% bupivacaine and 2% Li |
Brief summary describing the background
and objectives of the trial
|
Medial episcleral peribulbar anesthesia has been shown to be a valid alternative for ocular regional anesthesia, because of the infrequent complications observed. The site of injection is relatively a vascular. Articaine is a new local anesthetic drug used in eye surgery with dense motor block and fewer complications.
The current study demonstrates that peribulbar episcleral technique with 2% articaine and epinephrine 5ug/ml was effective and provide a superior option to a mixture of 0.5% bupivacaine/ 2%lidocaine. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,cataract surgery,Eye Diseases,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
15/03/2015 |
Actual trial start date |
16/03/2015 |
Anticipated date of last follow up |
12/05/2015 |
Actual Last follow-up date |
10/03/2015 |
Anticipated target sample size (number of participants) |
80 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Recruiting |
Publication URL |
|
|